May 2020 Feature: Revolution in Glaucoma Medications Read this Issue
-
The first sustained-release medication for glaucoma, an intracameral implant, was approved by the FDA in March -
The three recently approved agents for the treatment of glaucoma excluding sustained- release drugs are... -
Maximum medical therapy is better defined as maximum tolerated medical therapy -
There are many potential barriers to adherence in glaucoma medical therapy
Supplements View Archives: CME Non-CME
-
DEC 2019: Managing ocular surface disease in a preoperative cataract or refractive surgery patient -
DEC 2019: Improving the cataract patient experience: Minimizing pain and inflammation while reducing the need for topical drops -
November 2019: Toric Toolbox: Building skills and strategies to surgically manage astigmatism -
September 2019: Meibography Summit: Better understanding of meibomian gland dysfunction and how to integrate meibography in diagnosis and treatment planning -
July 2019: Advancing Surgical Outcomes: Algorithm launches new era in preoperative OSD management -
May 2019: Innovations advancing cataract surgery -
May 2019: Therapeutic solutions: Ocular surface disease and episodic flares of dry eye disease -
October 2018: Examining meibomian gland dysfunction and its impact -
March 2018: Customizing modern OSD therapies to individual patient needs
